Karthik Venkatakrishnan, PhD

Karthik Venkatakrishnan is Vice President and Global Head of Quantitative Pharmacology at EMD Serono, Inc., Billerica, MA. In this role, he is accountable for leadership of Clinical Pharmacology, Translational Modeling and Simulation, and Pharmacometrics in support of global R&D in the therapeutic areas of Oncology, Immuno-Oncology, Neurology and Immunology, and Lifecycle Management for marketed products. Prior to joining EMD Serono in 2020, Karthik held roles in Clinical Pharmacology at Pfizer Inc. and Takeda Pharmaceuticals, most recently as Head of Quantitative Clinical Pharmacology at Takeda Pharmaceuticals International Co., Cambridge, MA. Karthik’s areas of professional and research interest include Oncology R&D, Model-Informed Global Drug Development, and topics in translational science at the interface of drug metabolism and clinical pharmacology. Karthik received his Ph.D in Pharmacology and Experimental Therapeutics at Tufts University, Boston. Karthik is a Fellow of the American College of Clinical Pharmacology and a member of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), having served as Chair (2013-2014) of the ASCPT Scientific Program Committee and Chair (2017-2018) of the ASCPT Quantitative Pharmacology Network. He is an author of over 150 scientific publications and over 50 abstracts, and recipient of the ASCPT Clinical and Translational Science Award in 2018 and the ASCPT Malle Jurima-Romet Mid-Career Leadership Award in 2021. Karthik is an Associate Editor of Clinical Pharmacology and Therapeutics, and a Consulting Editor of Clinical Therapeutics. He is a member of the Editorial Boards of Clinical and Translational Science, The Journal of Clinical Pharmacology, and Clinical Pharmacology in Drug Development. Karthik is an Adjunct Assistant Professor at Tufts University School of Medicine, Boston, MA.